Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
|Format:||Government Document Online Book|
U.S. Government Printing Office,
|Online Access:||ONLINE VERSION|
No Tags, Be the first to tag this record!